unknown
Stage
1
Investors
About
Cardiovolt develops AI-powered ECG analysis technology that predicts and diagnoses cardiovascular diseases by extracting digital biomarkers from standard 12-lead ECG recordings, validated on over 5 million ECGs globally.
Explore Cardiovolt's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.